DexCom, Inc. (Nasdaq: DXCM), a global leader in real-time continuous glucose monitoring for people with diabetes, today announced a significant advancement in access to its products for those treating ...
DexCom projects 2025 revenue of $4.6 billion, representing 14% growth. This forecast assumes strong demand for CGM systems, expanded reimbursement coverage, and a second-half launch of a 15-day G7 ...
Medical Device Network on MSN
Dexcom gives sneak preview of CGM technologies’ long-term health benefits for diabetics
Dexcom will present the full data from several studies at the Advanced Technologies and Treatments for Diabetes conference, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results